Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Kvasnicka

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2001
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Der Pathologe|December 22, 2005
[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma]P Borchmann, K Behringer, A Josting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trialH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Annals of Hematology|July 1, 1997
Hematopoietic turnover index in reactive and neoplastic bone marrow lesions: quantification by apoptosis and PCNA labelingJ Thiele, T K Zirbes, J Lorenzen, et al.
Bone Marrow Transplantation|September 1, 2000
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1996
Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric studyJ Thiele, T Zirbes, H M Kvasnicka, et al.
Annals of Hematology|June 1, 1993
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrowJ Thiele, H M Kvasnicka, B R Titius, et al.
American Journal of Clinical Pathology|July 8, 2000
Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic featuresJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Histology and Histopathology|February 10, 2007
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantationJ Thiele, E Varus, U Siebolts, et al.
American Journal of Hematology|September 1, 1995
Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot studyJ Thiele, H M Kvasnicka, N Niederle, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2001
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Der Pathologe|December 22, 2005
[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma]P Borchmann, K Behringer, A Josting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trialH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Annals of Hematology|July 1, 1997
Hematopoietic turnover index in reactive and neoplastic bone marrow lesions: quantification by apoptosis and PCNA labelingJ Thiele, T K Zirbes, J Lorenzen, et al.
Bone Marrow Transplantation|September 1, 2000
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1996
Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric studyJ Thiele, T Zirbes, H M Kvasnicka, et al.
Annals of Hematology|June 1, 1993
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrowJ Thiele, H M Kvasnicka, B R Titius, et al.
American Journal of Clinical Pathology|July 8, 2000
Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic featuresJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Histology and Histopathology|February 10, 2007
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantationJ Thiele, E Varus, U Siebolts, et al.
American Journal of Hematology|September 1, 1995
Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot studyJ Thiele, H M Kvasnicka, N Niederle, et al.
Pageof 11